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ABSTRACT 
Over $10 billion losses in the poultry industry were caused by avian influenza (AI) so far. 
Rapid and specific detection of avian influenza virus is urgently needed with the concerns over 
the outbreaks of highly pathogenic H5N1 influenza virus and cases of animal and human 
infection. Aptamers are oligonucleic acid or peptide molecules that bind a specific target 
molecule with good affinity. They show better thermal stability than antibodies. The goal of this 
research was to select DNA-aptamers as the specific recognition element of AI H5N1virus to be 
used in detection assays specific for field application. In this study, Systematic Evolution of 
Ligands by EXponential enrichment (SELEX) was used to select DNA aptamers targeted to 
hemagglutinin (HA) and neuraminidase (NA) proteins of AI H5N1 virus. In the first four cycles 
of selection, aptamers were selected by incubating HA proteins with a DNA library starting from  
10
14
 molecules randomized at central 74 nt and subsequent nitrocellulose filtration. Then 
aptamers were eluted from filters and amplified by PCR. Single stranded DNA aptamers were 
derived from these double stranded DNAs by λ digest and were used as input for the next 
selecting cycle. In the following 9 cycles of selection, H5N1 virus was incubated as a substitute 
of NA proteins with aptamers pool in SELEX process. After 13 cycles of isolation, 115 bp DNA-
aptamers were screened out and three apatmer sequences were obtained after cloning. Results of 
Dot ELISA and Dot Blot showed that these DNA-aptamers have stronger binding specificity and 
affinity to AI H5N1 subtype compared with their binding to H5N2, H5N3, H5N9, H2N2, H7N2 
and H9N2. SPR test detected binding affinity of  aptamer O16 to HA protein KD is 4.65×10
-9
 M 
and a linear equation between y (SPR signal) in RU and x (virus titer) in HAU was described as: 
y=208.39x +2.2347 (R2=0.99). But SPR results showed aptamers had weak cross-reaction with 
H5N2. Theses selected aptamers could be applied to detection of AI H5N1 virus in the future. 
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        High-pathogenicity avian influenza (HPAI) causes rapid mortality in poultry, which often 
approaches 100% of incidences (Alexander, 2000). Recently, continuous outbreaks of HPAI 
have been reported in Asia and Europe (Horimoto and Kawaoka, 2005). AI virus H5N1 was first 
reported in 1997 in Hong Kong (Saw et al., 1997; Mounts et al., 1999). 
       The link between human and animal infection has raised concern among public health 
authorities and the scientific community about the prevalence and pandemic potential of AI virus. 
In the past several years, there has been a substantial increase in the number of AI outbreaks in 
poultry flocks and the number of countries reporting outbreaks continues to increase (Capua and 
Alexander, 2004; Zhao et al., 2005; Capua and Marangon, 2006). From 1999 to 2003, more than 
50 million birds died or were eradicated after an outbreak of HPAI in the European Union 
(Capua and Alexander, 2004). In the US, a recent outbreak of low pathogenic AI (LPAI) in 2001 
and 2002 resulted in the depopulation of over 4.5 million chickens and turkeys and is estimated 
to have cost the poultry industry approximately $125 million (Dunn et al., 2003). There are 502 
confirmed human cases and 298 deaths reported by WTO until July 2010 (WHO, 2010). 
        As a result, pathogenic AI virus H5 and H7 represent a potential danger not only to poultry 
but also to human health. Therefore, in addition to containment procedures, sensitive detection 
assays for early diagnosis are vital to lower the chances of spread and reduce the risk of 
development into an epidemic. Rapid and specific detection of avian influenza (AI) virus is 
becoming increasingly important and urgent in the face of concerns over the outbreaks of highly 
pathogenic AI H5N1 and the cases of human infection. Among AI subtypes, only the 
representatives of subtype H5 and H7 have been shown to exhibit highly pathogenic 
characteristics and to cause disastrous epidemic disease. The technology of diagnosing AI 
infections is available, such as viral culture, RT-PCR and ELISA methods, but many tests are too 
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complex and some can be performed only in biosafety level 3 facilities. Therefore, we proposed 
in the research to develop a DNA-aptamer based SPR biosensor coupled with magnetic bio-
nanobeads separation for rapid, specific, sensitive, inexpensive and simultaneous detection of AI 
pathogenic virus H5 in less than 1 h in the field or at the patient‘s bedside. 
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2.1 Overview of Avian Influenza Virus 
Avian influenza is an infection caused by avian influenza viruses. These influenza viruses 
infections occur naturally among birds. Wild birds worldwide carry the viruses in their intestines, 
seldom getting sick from them. However, contagious avian influenza can make some 
domesticated birds, including chickens, ducks, and turkeys, very sick and kill them (CDC, 2007). 
Influenza A (H5N1) virus, also called ―H5N1 virus‖, is an influenza A virus subtype that 
occurs mainly in birds, is highly contagious among birds, and can be deadly to them. H5N1 virus 
does not usually infect people, but infections with these viruses have occurred in humans. Most 
of these cases have resulted from people having direct or close contact with H5N1-infected 
poultry or H5N1-contaminated surfaces (WHO, 2007). 
Avian Influenza Virus is 80-120 nm diameter single-strained, negative-sense ribonucleic 
acid (RNA) viruses with a segmented genome. It can be further classified into various subtypes 
on the basis of their surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA) proteins 
(Murphy and Webster, 1996). So far there are sixteen HA (H1 through H16) and nine NA (N1 
through N9) (Fouchier et al., 2005). Influenza virus specificity for the host is mediated by the 
viral surface glycoprotein hemagglutinin (HA), which binds to receptors containing glycans with 
terminal sialic acids. The molecular-recognition process leads to the host cell-virus adhesion 
stage (Paulson et al., 1985). The sialic acid receptor of various influenza virus strains differs in 
affinity to sialic acids terminally linked either in α (2, 3) or α (2, 6) position to the galactose (Gal) 
residues. Human influenza A virus preferentially recognize the α (2, 6)-linkage, while avian 
virus have preference to the α (2, 3)-linkage (Rogers and Paulson, 1983). Each monovalent sialic 
acid-binding site of HA is weak, with dissociation constants in the mill molar range, while the 
high virus-cell affinity is due to multivalency (Glick et al., 1991).  
6 
 
2.2 Current Diagnostic Techniques for Influenza Virus 
       Traditional diagnostic methods and rapid diagnostic methods frequently used in current 
detection for Influenza Virus were concluded in Table 2.1 and 2.2 
 
Table 2.1 Traditional Influenza Diagnostic Methods  
(Centers for Disease Control and Prevention, 
http://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm) 
Procedure  
Influenza 
Types 
Detected  
Acceptable Specimens  
Time for 
Results  
Viral culture  A and B  Nasopharyngeal(NP) swab, 
throat swab, nasal wash, 
bronchial wash, nasal aspirate, 
sputum 
3-10 days 
Immunofluorescence  
DFA Antibody Staining 
A and B  NP swab, nasal wash, bronchial 
wash, nasal aspirate, sputum  
2-4 h  
RT-PCR A and B  NP swab, throat swab, nasal 
wash, bronchial wash, nasal 
aspirate, sputum 
2-4 h 
Serology  A and B  paired acute and convalescent 
serum samples 
2 weeks or 
more  
Enzyme Immuno Assay 
(EIA) 
A and B  NP swab, throat swab, nasal 
wash, bronchial wash 
2 h  
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Table 2.2 Rapid Diagnostic Methods for Influenza Disease  
(Centers for Disease Control and Prevention, 
http://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm) 
 
Procedure 
Influenza 
Types 
Detected 
Acceptable Specimens Time for Results 
3M™ Rapid Detection 
Flu A+B Test(3M) 
A and B NP swab/aspirate; Nasal 
wash/aspirate 
15 min 
Directigen EZ Flu A+B 
(Becton-Dickinson) 
A and B  NP wash/aspirate/swab; lower 
nasal swab; throat swab; 
bronchioalveolar lavage 
less than 15 min 
BinaxNOW Influenza 
A&B (Inverness) A and B Nasal wash/aspirate, NP swab less than 15 min 
OSOM® Influenza 
A&B 
(Genzyme) 
A and B Nasal swab less than 15 min 
QuickVue Influenza 
Test (Quidel) 
A and B NP swab, nasal wash, 
nasal aspirate 
less than 15 min  
QuickVue Influenza 
A+B Test (Quidel) 
A and B NP swab, nasal wash, 
nasal aspirate   
less than 15 min  
SAS FluAlert 
(SA Scientific) 
A and B  Nasal wash/aspirate  less than 15 min  
TRU FLU 
(MeridianBioscience)  
A and B Nasal wash/swab, NP 
aspirate/swab 
15 min 
XPECT Flu A&B 
(Remel) 
A and B  Nasal wash, NP swab, throat 
swab  
less than 15 min 
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The ideal diagnostic method would have high sensitivity and specificity for the 
identification of influenza, would be relatively simple to administer, and would be rapid and 
inexpensive. The timeliness of results is critical because, in order to be effective, the newer 
therapies (as well as the more traditional antiviral therapies for influenza A must be started 
within 48 h after onset of symptoms. As test accuracy improves or cost falls, the argument for 
diagnostic testing is enhanced. Regardless of the sensitivity and specificity of each test, the 
positive predictive value of any test will improve when the prevalence of influenza in the 
community is high. On the other hand, as the likelihood of influenza illness increases (such as in 
major outbreaks), the effectiveness and tolerability of treatment improve, or the cost of treatment 
decreases, an advantage is realized for empiric treatment based on clinical characteristics alone 
(Cram et al., 1999). 
The golden standard virus detection method is based on virus isolation culture with rapid 
immunoassay procedure, such as direct immunofluorescent assay or membrane enzyme-linked 
immunosorbent assay, followed by characterization with serological or molecular biological 
methods (Stamboulian et al., 2000; Boon et al., 2001). However, they are time consuming, poor 
in specificity, and low in sensitivity. On the other hand, RNA based methods, especially RT-PCR, 
has gained tremendous ground as an effective tool for viral detection, typing and subtyping 
(Zhang and Evans, 1991). But RNA based methods are still typically time-consuming to conduct 
since the protocol requires a series of RNA isolation, concentration, and gel electrophoresis. 
Fig.2.1 shows golden standard virus detection process for Influenza Virus. 
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Fig.2.1. Flow chart of isolation and identification of Avian Influenza Virus 
AI specimens 
- Diagnostic specimens 
- Surveillance swabs 
 
Specimen processing 
- Filtration, or 
- Antibiotic treatment 
 
Egg inoculation 
- SPF eggs 
- 9-11d ECE 
 
CAF harvesting 
- 3-4 d or up to 7d pi 
- CAF pool per sample 
 
HA test 
- 96 well microplate HA 
- Or slide spot HA 
 
HA positive:  
 Virus identification by any of the 
following assays 
HA negative: 
 Inoculation next passage if 
required 
 
Real-time RT –PCR 
- AIV matrix(group) 
- H5 subtype 
- H7 subtype 
 
Monoclonal antibody-based 
immunoassays 
- Direction for AIV group,or 
- Dot-ELISA for AIV,H5,H7,or 
Other antigen-capture assays 
 
        HI test 
- NDV 
- H5 subtype 
- H7 subtype 
 
AIV positive, send to State of 
Regional Lab (NVSL in USA) for 
- AIV confirmation 
- Serotyping and pathotyping 
 
AIV negative, but NDV positive, send to 
State of Regional Lab (NVSL in USA) 
for   NDV confirmation and pathotyping 
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2.3   Biosensors for Influenza Virus Detection 
Rapid detection techniques should provide reliable, real time, on-field, user-friendly, and 
inexpensive detection with improved or equivalent sensitivity, specificity and reproducibility of 
culture-based tests (Alocilja and Radke, 2003). Current interest has focused in developing new 
influenza sensors for quick and reliable testing for influenza with minimum sample handling and 
laboratory skill requirement. One of the strategies is to develop single step direct sensing 
methods that eliminate separation, incubation or use of any signal-reporting agents. According to 
Lazcka et al. (2007), biosensor technology is the fastest growing area in rapid pathogen detection. 
In recent years, various biosensors have been studied as alternatives to conventional methods for 
detection of influenza viruses. The commonly used biological recognition elements in biosensor 
platforms are antibodies and nucleic acid probes. Compared to conventional diagnostic 
technologies, the biosensor has the following advantages: 
1) Fast: biosensor has the potential to detect AI virus in less than 1 hr. 
2) Reusable: sensing surface throughout a number of assay cycles can be reused. 
3) Minimal requirement on sample handing and laboratory skill. 
4) Quantifiable: electrical signal can be further processed to get extensive information. 
Non-labeling techniques such as surface plasmon resonance (SPR) and quartz-crystal 
microbalance (QCM) have shown high promise in sensor research and gained momentum in 
detection of viral samples. Detection limits of QCM and SPR are both around the sub-nanogram 
region. Because the molecular weight of influenza A/B virus is about 2.5×106, the detectable 
number of virions is considered to be around 106. Another promising method is colorimetric 
sensors with functional polymers, which can provide a litmus test type of detection.  
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QCM has shown high promise in sensor research and gained momentum in detection of 
influenza virus even they have limited success in specificity (Schofield and Dimmock, 1996; 
Kortt et al., 1999; Sato et al., 1999).  
Surface Plasmon Resonance (SPR) is a direct optical-sensing technique (Homola, 2003). 
Its label-free detection scheme together with very high sensitivity offers enormous opportunity 
and flexibility to biosensing assay development (Cooper, 2003). The principle of SPR has been 
the subject of several reviews (Sambles et al., 1991). Judging from the increasing number of 
publications, it is clear that surface plasmon resonance has techniques for detection of various 
biochemical analytes (Mullett et al., 2000). Surface plasmon resonance has been used for 
detection of influenza virus and the study of interactions that involve viral proteins and receptors. 
The first use of SPR in influenza virus detection was reported by Schofield and Dimmock (1996). 
The sensor chip was coated with carboxylated dextran polymer matrix, on which monoclonal 
antibody HC10 for capture of influenza virus was coupled. Influenza virus was injected into the 
flow system, and the binding affinity with the surface antibody was monitored. The dissociation 
rate constant and association rate constant were found similar to those obtained with an affinity 
ELISA. The study demonstrates the feasibility of affinity measurements and detection for large 
virus particles by SPR. This study was followed by Critchley and Dimmock (2004) who studied 
the binding of influenza A virus to a neomembrane composed of bovine brain lipids that contains 
sialoglycolipids. The detection of plant viruses has also been successfully demonstrated by SPR 
(Boltovets et al., 2002). For the binding affinity area, Takemoto et al. (1996) developed a binding 
assay to study the interaction between influenza hemagglutinin and its cell surface receptor. 
Low-pH-induced BHA rosettes bind specifically to the fetuin-derivitized sensor surface, but not 
to an asialofetuin-derivitized sensor surface. The association rate, dissociation rate, and 
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dissociation constant for the multivalent interaction between BHA rosettes and the fetuin-
derivitized sensor surface were measured, enabling quantitation of the multivalent binding 
between BHA rosettes and the fetuin- derivitized sensor surface. Kortt et al. (1999) measured the 
binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase, 
isolated from tern and whale. A contribution of mass transport to the kinetic constants was 
demonstrated at higher surface densities and low flow rates, and was minimized at low ligand 
densities and relatively high flow rates (up to 100 ml/min). Nice et al. (1996) examined the 
interactions between two monoclonal antibodies and their corresponding Fab‘ fragments with a 
synthetic peptide. The peptide corresponds to the C-terminal 23 residues of the HA1 chain of 
influenza virus hemagglutinin. The IgGs were found to have equilibrium association constants 
(KA) 10 to 20-fold higher than the corresponding Fab‘ fragments. 
There is much interest in developing new SPR influenza biosensor for quick and reliable 
testing for influenza. SPR biosensor has the advantage of simplifying the analytical procedure by 
reducing need for labeling replaced by detecting the analyte itself. Very limited papers have been 
published about SPR influenza biosensor, which were based on antibody-antigen binding 
(Schofiled and Dimmock, 1996; Kortt et al., 1999) or sialic acid binding (Critchley and 
Dimmock, 2004), and so far, there is no report about SPR biosensor combining with magnetic 
bio-nanobeads separation and used for in-field swab sample AIV test of swab samples. 
 
2.4 Aptamers 
        There is new emerging area of aptamers‘ application in detection. Aptamers, whose name is 
derived from the Latin word aptus meaning ―to fit‖, are oligonucleotides (DNA or RNA) that can 
bind with high affinity and specificity to a wide range of target molecules, such as drugs, 
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proteins or other organic or inorganic molecules (Jayasena, 1999; Patel and Suri, 2000; Clark and 
Remcho, 2002; Luzi et al., 2003; You et al., 2003). Aptamers are generated by an in vitro 
selection process called SELEX (systematic evolution of ligands by exponential enrichment). 
SELEX was first reported in 1990 (Ellington and Szostak, 1990; Tuerk and Gold, 1990) and it 
has permitted the identification of unique RNA/DNA molecules, from very large populations of 
random sequence oligomers (DNA or RNA libraries). Selections are frequently carried out with 
RNA pools due to the known ability of RNAs to fold into complex structures which can be a 
source of diversity of RNA function, but single-stranded DNA pools can also yield aptamers 
(Marshall et al., 2000). Single-stranded DNAs are also known to fold in vitro into structures 
containing stem-loop, internal loops, etc., even if less stable than the corresponding RNA 
structures (Harada et al., 1994).  
        Aptamers show a very high affinity for their targets, with dissociation constants typically 
from the micromolar to low picomolar range, better than those of some monoclonal antibodies 
(Jenison et al., 1994). Aptamers have also been selected with a high binding specificity, as 
demonstrated by an anti-theophyllin aptamer that displays a 10,000-fold discrimination against 
caffeine (difference of only a methyl group) (Jenison et al., 1994). The large number of possible 
oligonucleotide sequences and their molecular diversity allow the isolation of aptamers with 
affinity for a large variety of molecules. High-affinity aptamers have been selected to bind an 
hundred different targets such as organic dyes (Ellington et al., 1992), amino acids (Famulok et 
al., 1992; Geiger et al., 1996), antibiotics (Schurer et al., 2001; Tereshko et al., 2003; 
Zimmerman and Maher, 2002), peptides (Baskerville et al., 1999), proteins (Klug et al., 1999).  
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       In comparison to antibodies, aptamer receptors have a number of advantages that make them 
promising in analytical and diagnostic applications. Table 2.3 shows properties comparison 
between aptamers and antibodies. 
 
Table 2.3 Physical Properties of Apatamers versus Antibodies Applied in Diagnostics 
                            Aptamers                  Antibodies 
In vitro selection is chemical process and target any 
protein under a variety of conditions 
generation requires a biological 
system and is limited to physiologic 
conditions 
 
Unlimited shelf life 
 
 
Limited shelf life 
Temperature stable 
 
Temperature sensitive, irreversible 
denaturation 
Uniform activity regardless of batch synthesis Activity of antibodies vary from 
batch to batch (polyclonal antibody) 
chemical modifications to molecule for diverse functions 
 
Limited modifications of molecule 
Binding affinity in low nanomolar to picomolar range Binding affinity in low nanomolar 
to picomolar range 
      The aptamer selection process can be manipulated to obtain aptamers that bind a specific 
region of the target and with specific binding properties in different binding conditions. After 
selection, aptamers are produced by chemical synthesis and purified to a very high degree by 
eliminating the batch-to-batch variation found when using polyclonal antibodies and, by 
chemical synthesis, modifications in the aptamer can be introduced enhancing the stability, 
affinity and specificity of the molecules. Finally, because of their simple structure, sensor layers 
based on aptamers can be regenerated more easily than antibody-based layers, are more resistant 
to denaturation and have a much longer shelf life (Mok and Li, 2008). 
Moreover, the selections process itself, with the amplification step, gives some 
advantages to aptamers with respect to other ―non-natural‖ receptors, such as oligopeptides, 
which cannot be amplified during their selection procedure. 
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The primary limitation on the use of aptamers (mainly RNA aptamers) as recognition 
elements has been their nuclease sensitivity which is very critical for their use in ex vivo and in 
vivo applications (Famulok et al., 2000). However, it has been shown that the stability of such 
molecules can be improved by chemical modification of the ribose ring at the 2-position (Pieken 
et al., 1991). Because the nucleases that are most abundant in biological fluids are the 
pyrimidine-specific nucleases, introduction of specific modifications at the 2- position of 
pyrimidine nucleotides (2-amino and 2-fluoro functional groups) protects an RNA 
oligonucleotide from degradation, increasing the half-life up to 15 h (Heidenreich and Eckstein, 
1992). Because 2-amino and 2-fluoro CTP and UTP can be incorporated into in vitro transcribed 
RNA, these modifications can be introduced into the combinatorial library. In this way, it has 
been possible to select aptamers with enhanced stability in biological fluids from libraries 
containing modified pyrimidines with 2-amino and 2-fluoro (Kusser, 2000). Due to all these 
characteristics, aptamers have been used in numerous investigations, as diagnostic tools (Brody 
and Gold, 2000) and for the development of new drugs. Moreover, aptamers have been recently 
used in analytical chemistry applications, as immobilized ligands or in homogeneous assays. 
 
2.5  SELEX Process 
Aptamers were discovered by the development of the SELEX (systematic evolution of 
ligands by exponential enrichment) process (Ellington et al., 1990; Tuerk et al., 1990) which is a 
technique for screening large libraries of oligonucleotides by an iterative process of in vitro 
selection and amplification.  
The SELEX process (Fig. 2.2) starts with the synthesis of a single-stranded library of 
oligonucleotides; each oligonucleotide comprises a central region of random sequence flanked 
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by a 5‘ and a 3‘ region of defined sequence. Each member in a library is a linear oligomer of a 
unique sequence.  
 
Random pool of oligos 
Selection of bound sequence 
HA/virus 
binding 
PCR amplification 
Partially mature pool 
Cloning and transformation into E.coli 
Randomly select 5-10 clones; 
Obtain cloned aptamer DNA by plasmid purification 
PCR amplification; 
Convert to single stranded DNA 
Repeated 
enrichment 
cycles 
Test affinity and specificity 
Clone best candidates target aptamers 
pool 
 
Fig. 2.2 Systematic evolution of ligands and exponential enrichment 
(SELEX) and DNA-aptamers selection scheme 
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The complexity of the library is dependent on the number of randomised nucleotides 
positions. Normally, the starting round contains 1013 to 1015 individual sequences, a very large 
number that permits to generate a high probability of selecting an aptamer specific for the target 
of interest. 
The chemically synthesised single-stranded DNA pool is amplified by polymerase chain 
reaction (PCR) in order to generate a double-stranded DNA pool. This is then either transcribed 
(for RNA selection) or strand separated (for single-stranded DNA selection) to convert it into a 
suitable form for selection (Wilson and Szostak, 1999). 
Three dimensional structures of these RNA/ssDNA sequences will result in a 
combination of Watson–Crick base-pairing and intramolecular interactions. To isolate aptamers 
to a given target molecule, the starting library of nucleic acids is incubated with the molecule of 
interest. The rare nucleic acid ligands, that adopt conformations that allow them to bind to the 
specific target, are partitioned by filtration through nitrocellulose (for protein target) or by 
affinity chromatography (normally for small molecules target). The population of molecules that 
bound the target is eluted and amplified by RT-PCR (for RNA libraries) or PCR (for DNA 
libraries) to have a new lower complexity pool enriched in target binding species that, in the case 
of RNA libraries, will be in vitro transcribed and used for the next selection/ amplification cycle. 
The enrichment of the high-affinity sequences at the expense of the low-affinity binders requires 
several iterations of the selection process carried out under increasing stringent conditions. A 
negative selection step is frequently employed by passing the nucleic acid pool over a cellulose 
filter in the absence of the target; this step eliminates the aptamers that bind the filters in a target-
independent manner (Luzi et al., 2003). The number of cycles required is dependent on the 
stringency imposed on each round as well as on the affinity of interaction between the target and 
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the aptamers. In general, around 8–15 cycles of affinity selection and amplification are needed 
before selecting an oligonucleotide population that is dominated by those sequences which bind 
the target best. Cloning and sequencing of the selected clones will reveal the sequence and the 
structure of the specific selected ligands. 
Once obtained this information, the aptamer can be generated by chemical synthesis. Its 
binding activity can be confirmed by different methods to validate its affinity and specificity for 
the target.  
Since most in vitro selection experiments take from weeks to months to be completed as 
described above, the SELEX process has been recently automated (Cox and Ellington, 2001; 
Cox et al., 2002a,b). A novel in vitro selection methodology has been also proposed by Golden et 
al. (2000). With this new photochemical SELEX (PhotoSELEX) method, modified ssDNA 
aptamers capable of photocross-linking the target molecule (human basic fibroblast growth 
factor (bFGF)) have been identified. The method is based on the incorporation of a modified 
nucleotide activated by absorption of light, in place of a native base in either RNA or in ssDNA-
randomised oligonucleotide libraries. The aptamers selected with this method have the ability to 
form a photo-induced covalent bond with the target molecule. 
 
2.6 Aptamer-based Biosensors  
Aptamer detection applications include aptamer-based microarrays (Collett et al., 2005), 
quantum-dot aptamer complexes (Levy et al., 2005; Hansen et al., 2006), aptamer-functionalized 
gold nanoparticles (Huang et al., 2005; Kouassi et al., 2007), and aptamer-based biosensors 
(aptasensors) (Deisingh, 2006; Willner et al, 2007; Fischer et al., 2007; Lee et al., 2008). 
Electrical and optical aptasensor platforms have been reviewed previously, including aptasensor 
19 
 
applications in biosecurity and clinical diagnostics (O‘Sullivan, 2002; Li et al., 2008; Song et al., 
2008). The application of aptamers as biocomponents in biosensors offers advantages over 
classical affinity sensing methods mainly based on antibodies. These advantages include  the 
possibility to easily regenerate the function of immobilized aptamers, their homogeneous 
preparation and the possibility of using different detection methods due to easy labeling 
(Jayasena, 1999; O‘Sullivan, 2002; Luzi et al., 2003; You et al., 2003).  
Aptamers have been used as bio-recognition element in optical sensors, both labelled 
(fluorescence-based methods) or in systems not requiring labels (surface plasmon resonance). 
Fluorophores remain one of the most prevalent signal transducers to be incorporated into 
aptamer biosensors, primarily thanks to the easy conjugation of fluorophores onto nucleic acid 
sequences and the convenience of detecting the fluorescence signals. The design and 
characteristics of these sensors are extensively discussed in a previous review by Nutiu and Li 
(2005). Immobilized optical sensors can be represented by unlabelled surface plasmon resonance 
biosensor. When light strikes the surface of a metal, especially silver and gold, at a particular 
angle, it can excite electrons on the surface, causing them to resonate and be propagated along 
the metal. This phenomenon, known as surface plasmon resonance (SPR), may be used to 
generate a signal to communicate target detection. The signal transducer used in SPR-based 
aptamer biosensors is generally gold covered disks coated with streptavidin. The presence of 
streptavidin, a biotin binding protein, enables the immobilization of biotinylated aptamers. When 
these chips are exposed to their targets, the interaction between the aptamers and their ligands 
would alter the local refractive index, and in turn change the surface plasmon resonance in 
response to excitation by the incident light. This fluctuation may be detected by monitoring the 
change in SPR angle, which is defined as the angle at which the reflected light reaches a 
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minimum intensity, following ligand binding. This system has been previously applied by 
Tombelli and colleagues for the detection of the HIV-1 Tat (trans-activator of transcription) 
protein (Tombelli et al., 2005) and by Tang and colleagues, who developed a sensor decorated 
with antithrombin DNA aptamers (Tang et al., 2007). 
The detection of changes in SPR and surface plasmon coupling does not always depend 
on sophisticated instruments as in the aforementioned sensors. In the case of gold nanoparticles 
(AuNPs), changes in SPR associated with the transition from the colloidal dispersion state to the 
aggregation state contribute to a red to violet color change that is observable with the naked eye 
(Okamoto et al., 2003). This unique property of AuNPs was recognized by mankind as early as 
the Middle Ages, when these particles were used in tainting stain glass and embellishing 
decorations with vibrant red and blue colors although the exact mechanism behind the color 
change was a mystery (Rao et al., 2000). In modern times, these particles are actively studied by 
the scientific community and new applications for them are constantly emerging. 
The development of oligonucleotide-modified AuNPs as probes for the selective and 
sensitive detection of complementary sequences by Mirkin and his coworkers back in 1997 
painted the possibility of chemically conjugating these particles with nucleic acids and exploiting 
their unique distance-dependent optical properties for signaling (Elghanian et al., 1997). Making 
use of oligonucleotide hybridization and AuNPs, Liu and Lu designed ATP and cocaine aptamer 
biosensors that use AuNPs as signal transducers (Liu et al., 2006). In this system, the aptamers 
are connected to a linker sequence. The nanoparticles are either functionalized with a sequence 
that is complementary to the 5‘ end of the linker or one that is complementary to the 3‘ end of 
the linker and part of the aptamer. When the target is absent, the linker and aptamer bind to both 
oligo 1 and oligo 2, thereby crosslinking the AuNPs and forming aggregates that appear violet 
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when suspended in solution. To accommodate their targets, the aptamers adopt folded structures, 
which displace oligo 2 while the linkers are still bound to oligo 1. This leads to the breakdown of 
the aggregates and a violet-to-red color change in solution. 
 
2.7 Dot ELISA 
Dot-ELISA (Enzyme Linked Immunosorbent Assay) is a commonly used immunological 
tool in diagnostic laboratories. Sandwich Dot-ELISA would be used in this study. Here viruses 
were immobilized onto a solid support and streptavidin-AP conjugate was linked to an enzyme. 
Biotin-labeled aptamer in the test sample first reacted with the immobilized virus and then with 
the second enzyme-linked conjugate. The amount of enzyme linked conjugate bound was 
assayed by incubating the strip with an appropriate chromogenic substrate, which was converted 
to a colored, insoluble product (Fig. 2.3).  
The latter precipitates onto the strip in the area of enzyme activity, hence the name Dot-
ELISA. The enzyme activity is indicated by the intensity of the purple spot, which is directly 
proportional to the antigen concentration. 
Dot ELISA was a good test kit because of its specificity and had high sensitivity when 
compared to standard immunobloting assay. According to references Pappas et al. (1983) and Lu 
(2003), The sensitivity and specificity of the Dot ELISA assay are better than standard micro-
ELISA. Meanwhile dot-ELISA is preferred compare to microwell ELISA test because it is 
simple to perform and needs less test time. 
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Fig. 2.3 Flow chart of sandwich Dot ELISA method in which biotin-labeled aptamers were 
linked to streptavidin-AP conjugate and viruses 
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Pathogenic AI virus H5 and H7 caused rapid mortality in poultry and threaten to human 
health. Research in diagnostics of AI virus lasted for a long time. But limited reports for rapid 
detection assays are available; especially little research is focused on aptamer based assays. 
Considering aptamers in terms of good affinity and advantage of better thermal stability over 
antibodies, this study was aimed to selecte aptamers for detection of H5N1 virus. 
In this study, SELEX (selective evolution of ligands by exponential enrichment) was 
designed to select DNA-aptamers, which could specifically recognize H5N1 AI virus. Then the 
selected aptamers would be characterized for their specificity and affinity using Dot ELISA and 
SPR test. Upon evaluation, these ssDNA aptamer would be used as recognition element of assays 
for rapid detection of AI virus H5N1.  
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4.1 Virus and Plasmid 
The influenza viruses used in the study were inactivated AIV H5N2, H5N3, H5N9, H1N1, 
H2N2, H7N2, H9N2 strain from Animal Diagnostic Laboratory, Pennsyvania State University 
and inactivated AIV H5N1 sample (Scotland 59 H5N1) from USDA-APHIS National Veterinary 
Services Laboratories (NVSL, Awes, IA). The pGEM T easy vector was obtained from Promega 
(Madison, WI). 
 
4.2 DNA library and Primers 
A pool of DNA oligonucleotides containing a region of randomized nucleotides (74 nt) 
flanked by constant sequences for binding of primers for PCR. The DNA oligonucleotides      
(5‘-CCGGAATTCCTAATACGACTC-N74-TATTGAAAACGCGGCCGCGG-3‘) was 
synthesized by IDT (integrated DNA Technologies). The forward primer biotinylated DL-F (5‘-
bio-CCGGAATTCCTAATACGACTC-3‘) and reverse primer phosphorylated DL-R (5‘- 
phosphate-CCGCGGCCGCGTTTTCAATA-3‘) were used to amplify the double strand 
aptamers candidates and ssDNA which were applied for the next selection cycle. 
 
4.3 Selection of DNA Aptamers Binding to H5N1 
Selection of DNA aptamers with a high affinity for H5N1 viruses was performed as 
follows. The DNA library mixed with H5N1 viruses. Then, the mixture passed through a filter. 
Few nucleic acids that reveal affinity and specificity towards the H5N1 stayed on the filter, while 
most of the library ingredients were washed away. The DNA-aptamer candidates were then 
eluted from the filter, and followed by PCR amplification. Subsequent selection cycles were 
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similar to the earlier ones with the exception that the stringency of selection would be increased 
to promote competition between biding species. Therefore, as the cycles progress, the molar ratio 
of HA to DNA (including pool DNA, nonspecific DNA) was increased from 1:20 to 1:500 
(Table 4.1). after 4 cycles, since NA proteins are unavailable, H5N1 virus was incubated as a 
substitute of NA proteins with aptamers pool in following nine cycles. 13 repeated separation-
amplification cycles yielded higher affinity and specificity DNA-aptamers. 
Table 4.1 Aptamers Binding with H5N1 Virus Mixture Ratios 
Cycle HA protein (μM) ssDNA Pool (μM) 
1 0.5 5.0 
2 0.25 5.0 
3 0.125 5.0 
4 0.063 5.0 
 H5N1 (μl) ssDNA Pool (μM) 
5 30 0.7 
6 25 1.7 
7 20 1 
8 15 0.8 
9 10 1.1 
10 5 0.85 
11 2 0.9 
12 1 0.8 
13 0.5 0.8 
 
4.3.1 SELEX 
Reagents used in SELEX included: binding buffer (50 mM Tris-HCl, 2.5 mM NaCl, 5 mM 
MgCl2, 10 mM dithiothreitol, PH 7.5), washing buffer (the same as binding buffer), elution 
buffer (0.4 M Sodium acetate, 5mM EDTA, 7M Urea, PH 5.5). 
The detail protocol for SELEX procedure was described as follows. 
1. 50 μl ssDNA, 1.5 μl glycogen and 50 μl Ammonium acetate (7.5 M) was dissolved in 0.25 
ml ethanol (100%). The solution was incubated for 30 min at -80 °C and then centrifuged 
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under 13000 rpm at 4 °C for 30 min. The pellet was washed with 75% ethanol solution (-
20 °C)(100 μl) twice and finally  resolved  in 100 μl binding buffer solution. Concentration 
of the ssDNA solution was measured  
2. 100 μl ssDNA solution was denatured at 95 °C for 10 min and cooled at room temperature 
for 30 min. 
3. Nitrocellulose acetate membrane (HAWP filter, 0.45 μl) was soaked in binding buffer 
solution for 1 min, and then the membrane was put into the filter holder. In order to 
eliminate ssDNA that bound to the membrane, the denatured ssDNA solution was passed 
three times prior to the selection cycle through pre-wetted membrane in ―pop-top‖ filter 
holders (see Appendix A).  
4. 100 μl denatured ssDNA solution and HA protein or H5N1 (128 HA unit) (according to 
mixture ratio in Table 4.1) were added into binding buffer to reach total solution volume of 
200 μl. Solution was incubated at 15 rpm on a variable speed rotator for 1 h at room 
temperature. 
5. 1 ml washing buffer (the same as binding buffer) was then passed through the membrane. 
6. ssDNA retained on the filter were eluted twice with 200 μl of elution buffer at 70-80 °C over 
the course of 5 min. 
7.  400 μl eluted ssDNA solution was separated into 2 tubes. 150 μl H20, 4.5 μl glycogen, 200 
μl Ammonium acetate (7.5 M) and 1 ml ethanol (100%) were added into each tube and 2 
tubes of solution were incubated for 30 min at -80 °C. Then solutions were centrifuged 
under 13000 rpm at 4°C for 30 min. Pellets were washed with 75% ethanol solution(-
20 °C)(100 μl) 2 times and resolved in 50 μl pure water. Finally they are ready for PCR. 
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4.3.2 Amplification and λ Digest of Aptamers Pool 
4.3.2.1 PCR 
        PCR was carried out in the following reaction mixture (Table 4.2) 
Table 4.2 NEB TAQ System for PCR Aptamers Pool 
  
Componets of PCR reaction Volume (μl) 
DNA template 1 
10×thermol buffer 5 
dNTP 4 
Forward primer DL-F-bio 1 
Reverse primer DL-R-phos 1 
Taq Polymerase 0.5 
dh20 37.5 
 
Amplification program was set as: 95 °C for 5 min followed by 30 cycles of 94 °C for 45 s, 
64 °C for 45 s and 72 °C for 45 s and lastly followed by 72 °C 10 min. 
4.3.2.2  λ Digest 
For the purpose of obtaining ssDNA aptamers pool, λ digest was performed at 37 °C for 1 
hr, following 75°C for 10 min (Table 4.3). 
Table 4.3 λ Digest Reaction Mixture for Converting dsDNA to ssDNA Aptamers 
 Sample (μl) Blank (μl) 
DNA template 40 0 
λ expo 1 1 
10×buffer 5 5 
Deionized water 4 44 
total 50 50 
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4.4  Cloning and Sequencing 
4.4.1 Ligation 
 pGEM-T Easy Vectors system was used in the ligation reaction. First, the pGEM-T Easy 
vector and control insert DNA tubes were briefly centrifuged to collect the contents at the bottom 
of the tubes. Then three ligation reactions were set up as described below (Table 4.4). 
Table 4.4 Ligation Reactions Mixture using pGEM-T Easy Vectors System 
 
Aptamers 
(μl) 
Positive 
Control (μl) 
Background 
Control (μl) 
2×Rapid Ligation Buffer,  
T4 DNA Ligase 
5 5 5 
pGEM T easy Vector (50 ng) 1 1 1 
Target DNA product 1 0 0 
Control Insert DNA 0 2 0 
T4 DNA Ligase  
(3 weiss units/μl) 
1 1 1 
Deionized water(μl)  2 1 3 
 
4.4.2  Transformation 
Transformation aimed to sequence aptamers was carried out in the following steps. 
1. Prepared two LB/ampicillin/IPTG/X-Gal (Sigma/Invitrogen) plates for each ligation reaction. 
Equilibrated the plates to room temperature. 
2. Centrifuged the tubes containing the ligation reactions to collect the contents at the bottom. 
Added 2 μl of each ligation reaction to a 1.5 ml sterile microcentrifuge tube on ice.  
3. Removed tubes of frozen JM109 High Efficiency Competent Cells (Promega) from storage 
and placed in an ice bath until just thawed (about 5 min). Mixed the cells by gently flicking 
the tube. 
4.  Carefully transfered 50 μl of cells into each tube prepared in Step 2. 
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5.  Gently flicked the tubes to mix and place them on ice for 20 min. 
6.  Heat-shocked the cells for 45–50 s in a water bath at exactly 42 °C (do not shake). 
7.  Immediately returned the tubes to ice for 2 min. 
8.  Added 950 μl room-temperature SOC medium (Invitrogen) to the tubes containing cells 
transformed with ligation reactions. 
9. Incubated for 1.5 h at 37°C with shaking (~150 rpm). 
10.  Plated 100 μl of each transformation culture onto duplicate LB/ampicillin/IPTG/X-Gal 
plates. For the transformation control, a 1:10 dilution with SOC medium is recommended for 
plating. To obtain a higher number of colonies, the cells were then pelleted by centrifugation 
at 1,000 × g for 10 min, resuspended in 200 μl of SOC medium, and 100 μl plated on each of 
two plates. 
11.  Incubated the plates overnight (16–24 h) at 37°C.  
 
4.4.3 Colony PCR  
Each colony was suspended in 20 μl PBS. Colony PCR was performed as follows (Tables 
4.5). PCR program was set as follows: diluted colonies were heated at 94 °C for 10 min and then 
reacted with other PCR system components 30 cycles of 94 °C for 30 s, 56 °C for 1 min and 
72 °C for 3 min and lastly followed by 72 °C 10 min. 
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Table 4.5 Colony PCR Mixture for Selected Aptamers‘ Amplification and Sequencing 
Components Volume (μl) 
Diluted Colony 1-2  
10 × buffer 5  
MgCl2 (25 mM) 4  
dNTP (2.5 mM) 4  
Forward primer DL-F (20 μM) 1  
Reverse primer DL-R (20 μM) 1  
Taq polymerase 0.5  
dH2O 32.5  
Total 50  
 
4.4.4  Sequencing 
     Sequencing was performed by ABI 3130xe analyzer (DNA Resource Center, University of 
Arkansas, Fayetteville).  
 
4.5 Evaluation of DNA Aptamers 
4.5.1  Dot ELISA Test 
Dot ELISA test was carried out first to do preliminary evaluation of DNA aptamers as 
follows.  
1. Used clean scissors to prepare test strips of nitrocellulose membrane, 60 mm×12 mm for 5 
specimens. Vinyl gloves must be worn at all times when handling the nitrocellulose 
membrane. 
2. Added 5 μl test viruses (H5N1, H5N2, H5N3, H7N2, H9N2) on strips and allowed them to 
air dry, marked the upper side of membrane with pencil. 
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3. Transferred the strips to a clean Petri dish and laid out one by one. Strips with different test 
specimens could be put together but should not be overlapped. 
4.  Added a blocking solution to the strips (pour solution into dish and cover every strip) and 
allowed strips to react for 15-30 min. After the reaction, removed the strips and laid out on 
chromatography paper to air dry. 
5. Transferred the strips into a new Petri dish and applied aptamers in an appropriate dilution 
(about 1:3, 50 μl ssDNA aptamers +100 μl blocking buffer) to the strips. Covered the entire 
strip surface with diluted aptamers (do not need pour, only added 150 μl on every strip) and 
allowed this reaction to go for 45 min. kept them float on a supporter in water bath to avoid 
drying during process. 
6. Strips were then washed with a wash buffer three times and each wash required a 5 min soak 
period. After washing, the washed strips were removed to allow them to air dry. 
7. Transferred the strips into another new petri dish and added 200 μl streptavidian-Alkaline 
Phosphatase conjugate at 1:500 dilution (diluted with blocking buffer), allowing this 
reaction to go for 25 min. 
8. Washed the strips and air dry. 
9. Transferred the strips into another new Petri dish and applied BCIP/NBT substrate to the 
strips. Maintained the strips and substrate in the dark to allow for color development, a 
purple color was evident within 5 min. (do not lasted too long time avoid of strong 
background). 
10. Stopped the color development by immersing the strips in water for 10-20 s. 
11. Allowed the strips to air dry in the dark. The strips could be stored in sealed plastic and kept 
in the dark to prevent the color from fading. 
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4.5.2  Dot Blot Test 
4.5.2.1 Dot Blot Test Materials 
        In Dot Blot test, Avian Influenza Virus H5N1 (NVSL, Awes, IA) and H5N2 (ADL, state 
college, PA) were prepaid as 1:100 dilution of stock sample. Biotin-ssDNA aptamers was 1:1 
diluted w/blocking buffer. Streptavidin-HRP conjugated (Perkin Elmar, Boston MA) was 1:1250 
diluted w/ blocking buffer. Blocking buffer was made of 2.5% (w/v) Casein, 0.15M Nacl, 0.01 m 
Tris and 0.02% Thimerosal; Adjust pH to 7.6 with NaOH.(reagents from VWR, Randor PA) 
Transfer buffer was made of 0.015 M Tris,0.12M Glycine, 20%(v/v) methanol(pH=8.3). 
(reagents from SIGMA, St. Louis MO) Substrate was Pierce Supersignal West Dura Extended 
Duration Substrate from Thermo Scientific, Rockford, IL. 
4.5.2.2  Dot Blot Test Protocol 
Dot Blot test was conducted as following steps: 
1. Soaked PVDF membrane in 100% methanol for 2 min. 
2. Incubated membrane in transfer buffer for 10 min to wet. 
3. Put PVDF in dot blot system and sealed system with vacuum. 
4. Loaded samples in wells of plate. 
5. Run vacuum on samples for 10- 20 min. 
6. Placed blot in blocking buffer for 1h on shaker. 
7. Incubated overnight in aptamers solution. 
8. Washed 3× for 5 min each with blocking buffer. 
9. Added streptavidin-HRP conjugated and incubated for 90 min. 
10. Washed 3× for 5 min each with blocking buffer. 
11. Added substrate (mix 1:1) in sealed bag and incubated for 5 min. 
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12. Removed substrate and placed blot in a plastic sheet protector. 
13. Took pictures with chemiluminescence using the CCD camera. 
 
4.5.3 Characterization of Selected Aptamers by Surface Plasmon Resonance 
4.5.3.1 SPR Test Instruments and Materials 
For all experiments, the SPR instrument SensiQ (ICx Nomadics, Oklahoma City, Ok) and 
neutravidin modified sensor chips (BioCap) were used. All experiments were conducted at 25 C 
with a flow rate of 10 µl/min. The running buffer used for the experiments was PBS (10mM, pH 
7.4). 10 mM NaOH (40 µl) were used for regeneration to remove the bound target protein HA 
(Hemagglutinin) or AIV H5N1. The full-length glycosylated recombinant HA  protein of the 
subtype H5N1 with concentration of 524 µg/mL was purchased from Protein Science 
Corporation (Meriden, CT). The protein was produced in insect cells using the baculovirus 
expression vector system and purified to 90% purity under conditions that preseve its biological 
activity and tertiary structure. Inactivated AIV H5N1 sample (Scotland 59 H5N1) was obtained 
from USDA-APHIS National Veterinary Services Laboratories (NVSL, Awes, IA). Selected 
aptamers O16 was use in the SPR test. 
4.5.3.2 SPR Test Methods 
Immobilization of the selected aptamer on SPR chip surface was carried out by using the 
biotin-neutravidin method. The SPR chip was pre-coated with neutravidin, and then biotin-
labeled aptamer with concentration of 1 µM was injected for 10 min (10 µl/min, 25 C) and then 
followed by 5 min biotin (10 µM) blocking.  
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For binding assay, HA proteins with different concentration (2, 5, 10, 20 and 40 µg/mL) 
were injected onto the sensor chip and the affinity binding was monitored for 2 min followed by 
washing with running buffer.  
The binding reaction equation of two macromolecular interactants (A and B) for a one-to-
one binding reaction is written as : 
 
KA = Ka / Kd = [AB]/[A][B] 
KD = Kd / Ka = [A][B]/[AB] 
Where Ka is the association rate constant in M
-1s-1 and Kd is the dissociation rate constant in s
-1. 
KA and KD are the equilibrium constants, KA is the association constant in M
-1 and KD is the 
dissociation constant in M. 
         After measuring SPR signals, the association and dissociation rate constants (Ka and Kd), 
and equilibrium association constants (KA) and dissociation constant (KD) were calculated by a 
1:1 [Langmuir] fitting model using the Qdata analysis software. 
Further experiments were conducted to study the binding affinity between the selected 
aptamer and the H5N1 virus with different titer of 0.064, 0.128, 0.32 and 0.64 HAU. Then the 
specificity was investigated by testing non-target AI virus H5N2, H5N9, H9N2, H7N2 and 
H2N2 with titer of 0.64 HAU. 
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CHAPTER 5 RESULTS AND DISCUSSION 
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5.1 Selection of DNA Aptamers 
      We performed an in vitro selection approach with a pool of DNA sequences totally 
randomized at 74 nt to select DNA aptamers that bind to AIV H5N1. Purified H5N1 strain (HA 
titer:128) and a DNA library of about 10
14
 different molecules with a length of 115 nt 
randomized at central 74 nt  (pool 74) were subjected to in vitro selection. The H5N1-binding 
DNA aptamers were selected by incubating HA with the DNA pool and subsequent 
nitrocellulose filtration. HA-bound aptamers were eluted from the filters, and then amplified by 
PCR.  
       Individual single-stranded aptamer DNAs were derived from an aliquot of this dsDNA stock 
by λ digest. Lambda exonuclease is a highly processive 5‘ to 3‘ exodeoxyribonuclease that 
selectively digest the 5‘-phosphorylated strand of dsDNA. Therefore, a 5‘-phosphorylated group 
was introduced into one strand of dsDNA by performing PCR where only reverse primer was 5‘-
phosphorylated. As a result, this phosphorylated strand  was then removed by digestion with 
lambda exonuclease while the other biotinylated strand was retained. The single strand DNA was 
used as the input for the next selection cycle. All DNAs were quantified by spectrophotometer 
and analyzed by PAGE gel (Figs. 5.1 and 5.2).  
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5.2   Cloning of DNA Aptamers 
        After 13 rounds of selection, ssDNA pool was purified using the Qiaquick PCR Purification 
Kit (Qiagen, Germany). The purified products were ligated to pGEM-T easy vectors (Promega), 
according to the manufacturer‘s instructions. Plasmids from individual white clones were ready 
to be sequenced. Fig. 5.3 shows screening results with controls. 
 
Fig. 5.3 (a)  
                     1       M 
               M: 25bp ladder; 
1: 3rd cycle ds-DNA aptamers 
Fig. 5.1 PAGE gel of 3
rd
 cycle ds-DNA  
aptamers selected by SELEX 
                                   M      1 
              M: 25bp ladder 
              1: 13
th
 cycle ds-DNA aptamers 
Fig. 5.2 PAGE gel of 13
th
 cycle ds-DNA 
         aptamers selected by SELEX 
115bp 
200bp 
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Fig. 5.3 (b)  
 
Fig. 5.3 (c)  
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Fig. 5.3 (d)  
Fig. 5.3 Blue/white screening test for 13
th
 cycle aptamers recombinants on LB agar plate 1 (c) 
and plate 2 (d) with positive control (a) and background control (b). 
 
        pGEM®-T Easy Vectors are linearized vectors with a single 3 -´terminal thymidine at both 
ends. The T-overhangs at the insertion site enhanced the efficiency of ligation of PCR products 
by preventing recircularization of the vector and providing a compatible overhang for PCR 
products generated by certain thermostable polymerases. Since pGEM®-T Easy Vectors are 
high-copy-number vectors containing T7 and SP6 RNA polymerase promoters flanking a 
multiple cloning region within the α-peptide coding region of the enzyme β-galactosidase, we 
chose  pGEM®-T Easy Vectors transformation system to screen recombinants. Insertional 
inactivation of the α-peptide allows identification of recombinants by blue/white screening on 
indicator plates. 
        As shown in Fig. 5.3 (a), positive control recombinants which contain a 542 bp fragment 
from pGEM®-luc Vector DNA appeared high ratio of white colonies. This vector DNA 
sequence has been mutated to contain multiple stop codons in all six reading frames, which 
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ensures a low background of blue colonies for the control reaction. On the other hand, Fig. 5.3 (b) 
indicates high efficiency competent cell JM109 works well on efficiency in the term of high 
background of blue colonies. 
        We picked up 30 white colonies randomly from each LB agar plate of blue/white screening 
test for 13
th
 cycle aptamers recombinants (Figs. 5.3 (c) and 5.3 (d))colonies were grown in LB 
media containing 50 μg/mL ampicillin (see Appendix B), and plasmid DNA was extracted with a 
Miniprep Kit (Qiagen). After evaluation of PCR results, aptmaers insert in the plasmid DNA of 
each clone were sequenced.  
 
5.3 Sequencing of DNA Aptamers 
Since there are some repeat sequences and wrong matches, we got three ssDNA aptamers 
sequences out of all positive colonies ultimately. Three sequences are shown below. 
O16 
GTGTGCATGGATAGCACGTAACGGTGTAGTAGATACGTGCGGGTAGGAAGAAA
GGGAAATAGTTGTCCTGTTG 
O20  
GGCCGAATTGGTTCGTCGAGCGAGTCACACCAACAATGCTGCGATAGAAACTT
CGTACGAGCTTTCTTACGCTG 
O10 
GACGGGTAACGTATGTTTTACATTACGAAATTTAGAGCACCCTTACAGCGAGAC
TCGTTGACCTGTAGCAGTG 
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        Considering the low rate of sequencing selection, we concentrated on these three sequences 
above and found that O20 has 74-nucleotide sequence while the other two have 73-nucleotide 
sequences. 
        O10 and O16‘s sequences show that it is unreasonable to obtain 73-nucleotide sequences of 
both. According to the mutagenic PCR theory (Cadwell et al., 2010), the error rate of Taq 
polymersae is high in the range 0.1 × 10-4 to 2× 10-4 per nucleotide per pass of the polymerase. 
So we can assume that in the amplification process, target aptamers O10 and O16 have mutation 
which changes 74-nucleotide sequences to 73-nucleotide sequences. 
 
5.4   Secondary Structure Prediction of DNA Aptamers 
 
Fig. 5.4 (a) 
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Fig. 5.4 (b)  
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Fig. 5.4 (c) 
Fig. 5.4 Secondary structure of aptamer O13 (a), aptamer O16 (b) and aptamer O20 (c) predicted 
by Mfold tool (http://mfold.bioinfo.rpi.edu/) 
        The aptamers sequences were analyzed and the secondary structures were predicted by 
means of the free energy minimization algorithm according to Zuker (2003) using the web server 
based mfold tool (http://mfold.bioinfo.rpi.edu/).  
        From Fig. 5.4 (a), a typical stem and loop motif was seen in the secondary structure of 
aptamers O13, which is predicted to be the binding region for the target. Aptamer O16 (Fig. 5.4 
(b)) represented the most common stem-loop style which connect several loops with stems 
together. However, aptamer O20 shows long stem and small loop structure (Fig. 5.4 (c)).   
        In general, the secondary structures of the aptamers are folded into a long stem–loop 
structure with a large internal loop and a couple of small bulges or loops.  
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5.5   Affinity and Specificity Evaluation of DNA Aptamers 
5.5.1   Dot Blot Test Results  
 
 
 
Fig. 5.5   Dot Blot results of 2
nd
, 8
th
, 9
th
, and10
th
 cycle ss-DNA aptamers pool reacted with 
H5N1/H5N2/H7N2 virus 
 
        First of all, Dot Blot test was conducted to check several rounds of aptamers pools‘ 
specificity and affinity. In Fig. 5.5, 2nd, 8th, 9th, and10th cycle ssDNA pools reacted with 1/100 
and 1/200 diluted H5N1 (128 HA) as well as H5N2 and H7N2 virus. Each cycle of ssDNA pool 
has specificity to H5 compared to H7 subtypes, and they also show specificity to H5N1 than 
H5N2 because ssDNA pool has little reaction with H5N2. 
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5.5.2 Dot ELISA Test Results 
 
                                                                          
                               Fig. 5.6 (a)                                                   Fig. 5.6 (b) 
Fig. 5.6  Dot ELISA results demonstrate 12
th
 cycle ssDNA (a) and 13
th
  cycle ssDNA (b) pool‘s 
affinity with subtype H5N1, H5N2, H5N3, H5N8, H5N9,H7N2 virus. 
 
        A newly developed Dot-ELISA, rather than standard Sandwich-ELISA, was used to detect 
aptamers pools‘ affinity. In the Dot-ELISA, viruses were immobilized on nitrocellulose strips 
which can detect aptamer targeted to virus. Then these attached biotin-labeled atapmer can react 
with steptavidin-AP conjugate through biotin- steptavidin interaction. The amount of enzyme 
linked conjugate bound is assayed by incubating the strip with an appropriate chromogenic 
substrate leading a color development. Therefore ssDNA pools were deemed to react with AI 
virus when strips appear purple dot on it. From comparison of 12
th
 and 13
th
  cycle ssDNA pool‘s 
affinity with subtype H5N1, H5N2, H5N3, H5N8, H5N9. H7N2 in Fig. 5.6, It‘s easy to conclude 
that ssDNA pools indicate strong specificity to H5N1 but little cross-interaction with other 
subtypes. 
        Upon quick and effective outcome of Dot ELISA test, specificity and affinity test for 
individual aptamers were continued to take. 
 
+ 
_ 
 
_ 
 
_ 
_ 
 
_ 
+ 
_ 
 
_ 
 
_ 
 
_ 
 
_ 
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Fig. 5.8 Specificity of aptamers to different 
H5/H7/H9 subtypes tested by Dot ELISA 
Fig. 5.7    Specificity of 
monoclonal anti–H5 antibody to 
different H5 and H7 subtypes tested 
by Dot ELISA as control 
5.5.2.1 Apatmer Specificity 
       
 
. 
         
After purification of three ssDNA aptamers, Dot ELISA test is applied first for their 
specificity test. As a comparison control shown in Fig. 5.7, anti-H5 monoclonal antibody (4.4. 
μg/mL from ADL, Penn State University) shows specificity on H5 subtypes and has no 
interaction with H7 subtype. Besides, aptamers O10, O13, O16 not only show specificity to H5 
subtype but also appear unique interaction with H5N1 (Fig. 5.8). Among those three aptamers, 
O16 performed best affinity on H5N1 according to their darkness of dot. From the above figures, 
we can make a preliminary conclusion that these three aptamers has good specificity to H5N1. 
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5.5.2.2 Aptamer Affinity 
 
                                     Fig. 5.9 Aptamer O16‘s affinity to H5N1 compared with  
                                                 anti H5 monoclonal antibodies‘ affinity to H5N1                            
        As the one of the best candidate aptamers, O16 was selected for further affinity test. In this 
Dot ELISA affinity test, H5N1 virus was diluted from 128 HA units to 0.0128 HA units. One 
g/ml O16 aptamer ssDNA was applied on the strip. The result shows the minimum virus 
concentration which can interact with aptamers O16 at that concentration is between 0.128 and 
1.28 HA unit. 
       Meanwhile, anti-H5 monoclonal antibodies at the same concentration to aptamers present 
almost the same minimum virus concentration of ELISA interaction. But they showed greatly 
less interaction with H5N1 than aptamers due to color comparison in Fig.5.9. Therefore, we can 
conclude that aptamer O16 represent equal even better affinity to H5N1 with contrast to anti-H5 
monoclonal antibody. 
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        Considering that the result cannot be quantitative and not be compared with antibody‘s 
affinity, further binding test and characterization of aptamers will be continued. 
 
5.5.3 SPR Test Results
*
 
The chip was ready for binding measurements after washing with running buffer. Aptamer was 
immobilized on Channel 1 and channel 2 without immobilization was used as a reference 
channel. The immobilization of aptamer resulted in increased 997 RU SPR signal. 
 
Fig. 5.10 An overlay of the SPR signals from the interaction between HA protein and aptamer 
        After HA proteins with different concentration (2, 5, 10, 20 and 40 µg/ml) were injected 
onto the sensor chip, the analytical signal, recorded in resonance units (RU), was computed as 
                                                 
*
 Results presented are from SPR test that was conducted by Dr. Ronghui Wang. Due to my 
healthy reason, I was absent from this experiment. 
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the difference between the aptamer and corresponding reference channel. We evaluated the 
affinity binding of HA protein to the selected aptamer by injecting increasing concentrations of 
HA over the aptamer and reference surfaces. In this way, the portion of the SPR signal that was 
attributed to specific affinity binding could be calculated by subtracting the non-specific binding 
and bulk refractive index effects detected on the reference surface from the total SPR signal 
measured on the aptamer surface. An overlay of the sensor SPR signals from the interactions 
between HA and the selected aptamer is shown in Fig. 5.10. As expected, injection of increasing 
HA concentrations resulted in an increase of the SPR signal. Analysis of data for interaction 
between HA and aptamer; association and dissociation rate constants (Ka and Kd), and 
equilibrium association constants (KA) were calculated by a 1:1 [Langmuir] fitting model using 
the Qdata analysis software. The calculated Ka and Kd was 4.6910
4 (M-1 s-1) and 2.1810-4 (s-1), 
respectively. So KA was 2.1510
8 (M-1) and KD was 4.6510
-9 (M), indicating strong binding 
between the HA protein and the selected aptamer. 
        The inactivated AI H5N1 virus with different titer of 0.064, 0.128, 0.32 and 0.64 HAU in 
buffer solution was tested using SPR. The result was shown in Fig. 5.11. The Standard 
Deviations (SDs) was indicated as error bars in the figure. A linear relationship was found and 
the corresponding equation was described as: y=208.39x +2.2347 (R2=0.99), where y (SPR 
signal) was expressed in RU and x (virus titer) in HAU. The result showed that the selected 
aptamer could be used as a ligand to detect target AIV H5N1. 
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Fig. 5.11 Detection of inactivated AIV H5N1 using the aptamer immobilized SPR 
        In specificity test non-target AI virus H5N2, H5N9, H9N2, H7N2 and H2N2 with titer of 
0.64 HAU were investigated. No detectable signal was obtained with AIV H5N9, H9N2, H7N2 
and H2N2. However, 33 RU SPR signal was observed when detection of AIV H5N2, showing 
some cross-interaction with subtype H5N2. 
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CHAPTER 6 CONCLUSIONS AND FUTURE RESEARCH 
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        In this study, Systematic Evolution of Ligands by EXponential enrichment (SELEX) was 
used to select DNA aptamers targeted to hemagglutinin (HA) and neuraminidase (NA) proteins 
of AI H5N1 virus. After 13 cycles of isolation, 115 bp DNA-aptamers were screened out and 
three apatmer sequences were obtained after cloning. The results of Dot ELISA, Dot Blot tests 
showed that those DNA-aptamers have stronger binding specificity to AI H5N1 subtype 
compared with their binding to H5N2, H5N3, H5N9, H2N2, H7N2 and H9N2. Aptamers also 
presented stronger binding affinity to AIV H5N1 than monoclonal anti-H5 subtype antibodies.  
        In further evaluation process, saturation curve was obtained in SPR analysis by plotting the 
response units (RU) as a function of H5N1 or HA protein concentration. The calculated Ka and 
Kd was 4.6910
4 (M-1 s-1) and 2.1810-4 (s-1), respectively. The KA was 2.8510
8 (M-1) and KD was 
4.6510-9 (M), indicating strong binding between the HA protein and the selected aptamer. A 
linear equation between y (SPR signal) in RU and x (virus titer) in HAU was described as: 
y=208.39x +2.2347 (R2=0.99), demonstrating that the selected aptamers O16 could be used as a 
ligand to detect target AIV H5N1. Specificity test by SPR showed weak cross-interaction with 
AI subtype H5N2. 
        In the future research, aptamers selected in this study could be used in assays as a specific 
recognition element for sensitive, specific and rapid detection of AI H5N1 virus. 
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APPENDIX A. Nitrocellulose Filter Binding Test in SELEX 
 
 
 
                       
Fig.A.1 Nitrocellulose Filter binding test equipment 
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APPENDIX B. Selected Aptamers Cloning Test 
 
 
Fig.B.1 Selected aptamers colonies grown in LB medium 
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